SCHEDULE: FMR LLC Discloses 4.7% Passive Stake in Kenvue Inc.
Beneficial Ownership Report
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting a 4.7% beneficial ownership in Kenvue Inc.'s common stock as of September 30, 2025.
Summary
- FMR LLC and Abigail P. Johnson collectively beneficially own 90,322,373.80 shares of Kenvue Inc. common stock.
- This aggregate amount represents 4.7% of Kenvue Inc.'s outstanding common stock.
- FMR LLC holds sole voting power over 54,101,208.75 shares and sole dispositive power over 90,322,373.80 shares.
- Abigail P. Johnson, as a control person of FMR LLC, is deemed to have sole dispositive power over the same 90,322,373.80 shares.
- The filing indicates that the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Kenvue Inc.
- FMR LLC is classified as a parent holding company or control person, while Abigail P. Johnson is an individual.
- Several FMR LLC subsidiaries, including FIAM LLC, Fidelity Institutional Asset Management Trust Company, Fidelity Management & Research Company LLC, Fidelity Management Trust Company, and Strategic Advisers LLC, are identified as entities beneficially owning shares.
Sentiment
Score: 5
Explanation: The filing is a routine disclosure of beneficial ownership by a large institutional investor. The 4.7% stake is significant but falls below the 5% threshold for more stringent reporting, indicating a passive investment stance without intent to influence control. This is generally neutral, reflecting portfolio management rather than a strong positive or negative signal about the company's prospects.
Industry Context
This filing reflects a passive investment by a major asset manager in Kenvue Inc., a company operating in the consumer health sector. Such disclosures are routine for large institutional investors and typically reflect portfolio management decisions rather than specific industry-wide trends, though the continued presence of large funds indicates ongoing institutional interest in the sector.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's stake, which can influence market perception and trading activity.
Key Dates
| Date | Description |
|---|---|
| 09/30/2025 | Date of event which requires the filing of this statement, reflecting the beneficial ownership percentage. |
| 11/04/2025 | Date the Schedule 13G Amendment No. 3 was signed by FMR LLC and Abigail P. Johnson. |
| 01/03/2023 | Effective date of Power of Attorney for FMR LLC, incorporated by reference. |
| 01/10/2023 | Date of Schedule 13G filing by FMR LLC where Power of Attorney was incorporated by reference. |
| 01/26/2023 | Effective date of Power of Attorney for Abigail P. Johnson, incorporated by reference. |
| 01/31/2023 | Date of Schedule 13G filing by FMR LLC where Abigail P. Johnson's Power of Attorney was incorporated by reference. |
Recommendation
holdThis Schedule 13G filing primarily discloses the beneficial ownership stake of FMR LLC and Abigail P. Johnson in Kenvue Inc. at 4.7%. As a passive filing, it does not contain information regarding Kenvue's financial performance, strategic initiatives, or operational outlook. Therefore, based solely on this ownership disclosure, there is insufficient fundamental data to warrant a 'buy' or 'sell' recommendation. A 'hold' recommendation is appropriate, acknowledging the continued institutional interest while awaiting more comprehensive financial or operational updates from Kenvue Inc.
Keywords
Kenvue Inc, FMR LLC, Abigail P. Johnson, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Schedule 13G, Consumer Health
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.